Newtopia Inc. (NEWUF)
| Previous Close | 0.0055 |
| Open | 0.0055 |
| Bid | 0.0055 x 0 |
| Ask | 0.0124 x 0 |
| Day's Range | 0.0055 - 0.0055 |
| 52 Week Range | 0.0055 - 0.0669 |
| Volume | |
| Avg. Volume | 1,085 |
| Market Cap | 952,957 |
| Beta (5Y Monthly) | -1.60 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0200 |
| Earnings Date | Nov 18, 2024 - Nov 30, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PR NewswireNewtopia Signs Framework Agreement with Supplemental Insurance Payvider to Offer its Proven Habit Change Platform to Thousands of U.S. Workers as a Fully-Covered Benefit
Newtopia Inc. ("Newtopia" or the "Company") (TSXV: NEWU) (OTCQB: NEWUF), a tech-enabled habit change provider focused on preventing, slowing, and reversing metabolic disease, is pleased to announce a new Framework Agreement with a supplemental insurance payvider ("Payvider") to offer its proven habit change platform to thousands of U.S. workers as a fully-covered benefit starting in 2025.
CNW GroupNewtopia Expands Proven GLP-1 Support Programs with Global Apparel Leader and Provides Update on its Strategic Process
Newtopia Inc. ("Newtopia" or the "Company") (TSXV: NEWU) (OTCQB: NEWUF), a tech-enabled habit change provider focused on preventing, slowing, and reversing chronic disease, is pleased to announce the expansion of its long-standing partnership with a global apparel leader for GLP-1 support. The expansion will make available Newtopia's proven GLP-1 Ally & Sustain programs to all employees and spouses taking GLP-1 medications. As such, Newtopia expects to enroll as many as 1,000 new participants fr
